InvestorsHub Logo
Followers 17
Posts 1103
Boards Moderated 0
Alias Born 04/07/2020

Re: justdafactss post# 138936

Thursday, 01/07/2021 2:54:26 PM

Thursday, January 07, 2021 2:54:26 PM

Post# of 233193
In the cancer testimonial you are referring to they mentioned the CTC dropping to zero. This could indicate a complete response to Leronlimab treatment. When Keytruda first entered the market it was a third line treatment, they recently got approval for first line. Revenue for Keytruda is nearly 4 billion annually and Keytruda only works on MSI patients, a small subset of cancer patients. Leronlimab is an immunotherapy similar to Keytruda.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News